abstract |
Provided is a novel neovascularization device. The neovascularization device contains a neovascularization component and a polymer. The polymer optionally contains, for instance, at least one or more polyvinyl alcohol resins (A) selected from: a modified polyvinyl alcohol resin (A1) having an active carbonyl group; a polyvinyl alcohol resin (A2) having triad syndiotacticity of 32 to 40%; and polyvinyl alcohol resin (A3) having a degree of saponification of 97 mol% or greater. |